Trademarks Filed by EYSYS PHARMACEUTICAL PRIVATE LIMITED

63 trademark applications recorded in the national registry under this applicant name.

The IP India register records 63 trademark applications filed by EYSYS PHARMACEUTICAL PRIVATE LIMITED. Filings run from 24 February 2021 to 8 May 2024. The portfolio is concentrated in Class 5 — Pharmaceuticals, which accounts for 95.2% of the filings, followed by Class 35 — Business & Retail Services at 1.6%. The most common registry status across the portfolio is DRAFT (1 mark).

63Applications
4Classes covered
Feb 2021First filing
May 2024Latest filing

Classes EYSYS PHARMACEUTICAL PRIVATE LIMITED Has Filed In

NICE classes ranked by applications filed under this name. Indian trademark protection extends only to the classes actually filed in — a class absent from this table is not covered by these registrations.
NICE classShare of portfolioApplications
Class 5 — Pharmaceuticals60 (95.2%)
Class 35 — Business & Retail Services1 (1.6%)
Class 42 — Technology & IT Services1 (1.6%)
Class 44 — Medical & Veterinary1 (1.6%)

Registry Status of These Filings

Status is the free-text value the registry records against each application. "Unknown" means no status had been published for that record at the last refresh.
StatusShare of portfolioApplications
Unknown62 (98.4%)
DRAFT1 (1.6%)

All Trademarks Filed by EYSYS PHARMACEUTICAL PRIVATE LIMITED

Every trademark application the register attributes to EYSYS PHARMACEUTICAL PRIVATE LIMITED, newest filing first. Each row links to that mark's full registry record.

  1. STOMIG
    App. No. 4957710Class 5Filed 27 Apr 2021
  2. ARTIGREL
    App. No. 4948634Class 5Filed 17 Apr 2021
  3. SGBLESS
    App. No. 4878822Class 5Filed 24 Feb 2021
    DRAFT

About this data

Source
Sourced from the official IP India trademark register and the Trade Marks Journal. Only records published by the registry are counted — never applications filed through Trademarx.
Grouped by
The applicant name recorded on each application, normalised for case, spacing and punctuation — so "EYSYS PHARMACEUTICAL PRIVATE LIMITED" and its other recorded spellings appear together on this page.
Refreshed
Hourly.
Known limitation
Marks a business holds under a group company, a subsidiary, or a founder's personal name are recorded against those names and appear on their own pages, not here.

Frequently asked questions

How many trademarks does EYSYS PHARMACEUTICAL PRIVATE LIMITED have?

63 trademark applications in the IP India register are filed under the name EYSYS PHARMACEUTICAL PRIVATE LIMITED, spanning 24 February 2021 to 8 May 2024. This counts filings recorded against that applicant name; marks held under a group company, a subsidiary, or a founder's personal name are recorded separately.

Which trademark classes does EYSYS PHARMACEUTICAL PRIVATE LIMITED file in?

Class 5 — Pharmaceuticals is the most-used class, with 60 filings — 95.2% of the portfolio. In total the portfolio covers 4 NICE classes. Indian trademark protection only extends to the classes actually filed in, so classes absent from this list are not covered by these registrations.

Can I use a brand name similar to one filed by EYSYS PHARMACEUTICAL PRIVATE LIMITED?

Not safely, if it is in a class this applicant already covers. A mark that is identical or deceptively similar to an earlier filing in the same or a related class can be refused by the registry or opposed after publication. Run a clearance search across the relevant classes before adopting a name.

How current is this data?

Sourced from the official IP India trademark register and the Trade Marks Journal. Only records published by the registry are counted — never applications filed through Trademarx. Status and class shown reflect what the Registry has on file at the time of the most recent refresh.

Checking a competitor, a partner, or your own portfolio?

Free clearance search, IP India authorised agents, filing from ₹1,499 + govt. fees.

Data sourced from the official IP India trademark registry and Trade Marks Journal, refreshed continuously. Search another company →